Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Director/PDMR Shareholding

3 Nov 2011 08:57

RNS Number : 4236R
S & U PLC
03 November 2011
 



3 November 2011

 S & U PLC ("S&U" or "the Company")

DTR 5.6.1 and Director/PDMR Shareholding

S&U have issued 10,000 ordinary shares of 12.5p each ("Ordinary Shares") in the Company in order to satisfy options issued under the Company 2008 DSOP. Following the issue of these Ordinary Shares the Company has 11,747,228 Ordinary Shares in issue. An application has been made to the London Stock exchange for these Ordinary Shares to be admitted to trading and admission is expected on 8 November 2011.

 

DISCLOSURE AND TRANSPARENCY RULES DTR 5.6.1 R

There are 200,000 6.0% Cumulative preference shares of £1 each in the Company and 3,599,106 31.5% Cumulative preference shares of 12.5p each in the Company.

S&U does not hold any shares in treasury.

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 11,747,228, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FSA's Disclosure and Transparency Rules.

 

Further to this issue, S & U were advised that the following Executive Directors exercised share options and sold Ordinary Shares on 2 November 2011.

 

Chris Redford exercised approved options over 4,000 Ordinary Shares granted in June 2008. He subsequently sold 3,000 of these Ordinary Shares at an average price of 615p per Ordinary Share. Following this transaction, the beneficial shareholding of Chris Redford is 1,000 Ordinary Shares representing 0.01% of the total voting rights of the Company.

 

Guy Thompson exercised approved options over 6,000 Ordinary Shares granted in June 2008. He subsequently sold 4,000 of these Ordinary Shares at an average price of 615p per Ordinary Share. Following this transaction, the beneficial shareholding of Guy Thompson is 2,000 Ordinary Shares representing 0.02% of the total voting rights of the Company.

 

 

For further information, please contact: 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777 

Broker and Financial Adviser

Adrian Trimmings/Jamie Cameron Arden Partners 020 7614 5920

 

Media and Investor Relations

Will Swan / Rebecca Whitehead Smithfield 020 7360 4900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSVXLBBFFFEFBZ
Date   Source Headline
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.